XAGRID caps 0.5 mg bte 100 pce

7680547200687 CH-54720 L01XX35 07.16.4.
XAGRID caps 0.5 mg bte 100 pce
XAGRID caps 0.5 mg bte 100 pce
XAGRID caps 0.5 mg bte 100 pce
1 / 3
google

Details

Product number
5472001
CPT
-
Packaging group
100
Unit
Kapsel(n)
Composition
anagrelidum 0.5 mg ut anagrelidi hydrochloridum monohydricum, povidonum K 30, lactosum 65.76 mg, lactosum monohydricum 53.74 mg, cellulosum microcristallinum, crospovidonum, magnesii stearas, Kapselhülle: gelatina, E 171, Drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, E 172 (nigrum), pro capsula.

Articles (1)

Xagrid 0,5 mg, Hartkapseln
Kapseln
100
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
13/06/2023
Patient information leaflet
Français
13/06/2023
Patient information leaflet
Italien
13/06/2023
Professional SmPC
Allemand
13/06/2023
Professional SmPC
Français
13/06/2023
Professional SmPC
Italien
13/06/2023

Detailed composition

Substance Quantity Type Category
(N/A)
0.5 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
65.76 MG Substance HBESI
(N/A)
53.74 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 240.45
Specialties list
Yes
Generic
No
SL addition date: 01/10/2000

Authorization holder

Takeda Pharma AG

8152 Opfikon

Authorization information

Swissmedic authorization number
54720
Drug name
Xagrid 0,5 mg, Hartkapseln
Galenic form
KAHA
ATC Code
L01XX35
Authorization status
Z
Dispensation category
B
First authorization
08/12/1999
Authorization expiration date
31/12/9999
IT number
07.16.4.
Domain
Human medicine
Field of application
Behandlung der essentiellen Thrombozythämie

Packaging details

Description (FR)
XAGRID caps 0.5 mg bte 100 pce
Description (DE)
XAGRID Kaps 0.5 mg Ds 100 Stk
Market launch
08/12/1999
Narcotic (BTM)
No